Swiss National Bank Purchases 3,600 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Swiss National Bank raised its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 1.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 201,200 shares of the company's stock after buying an additional 3,600 shares during the period. Swiss National Bank owned about 0.08% of Ryan Specialty worth $12,909,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Rakuten Securities Inc. bought a new position in Ryan Specialty in the 4th quarter worth $27,000. HighTower Advisors LLC raised its holdings in Ryan Specialty by 6.4% in the 4th quarter. HighTower Advisors LLC now owns 42,533 shares of the company's stock worth $2,729,000 after purchasing an additional 2,564 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Ryan Specialty by 18.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,268 shares of the company's stock worth $1,750,000 after purchasing an additional 4,199 shares in the last quarter. Dundas Partners LLP raised its holdings in Ryan Specialty by 24.7% in the 4th quarter. Dundas Partners LLP now owns 10,254 shares of the company's stock worth $658,000 after purchasing an additional 2,029 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in Ryan Specialty by 22.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,696 shares of the company's stock worth $301,000 after purchasing an additional 846 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.

Remove Ads

Ryan Specialty Stock Down 0.8 %

NYSE:RYAN traded down $0.56 on Friday, reaching $71.13. 1,096,671 shares of the stock traded hands, compared to its average volume of 910,140. The company has a market capitalization of $18.63 billion, a price-to-earnings ratio of 103.09, a PEG ratio of 1.19 and a beta of 0.71. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $75.97. The company's fifty day simple moving average is $68.11 and its 200 day simple moving average is $67.98.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Equities analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is presently 69.57%.

Analyst Upgrades and Downgrades

Several brokerages have commented on RYAN. Royal Bank of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a report on Friday, February 21st. Morgan Stanley began coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price target for the company. Wells Fargo & Company increased their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research note on Friday, February 21st. Finally, UBS Group increased their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $75.27.

Insider Activity

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the sale, the director now directly owns 35,609 shares in the company, valued at approximately $2,349,837.91. The trade was a 49.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 241,360 shares of company stock valued at $16,006,428 in the last 90 days. 11.10% of the stock is currently owned by insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.